Pulse Biosciences (PLSE) Operating Expenses (2015 - 2025)

Pulse Biosciences' Operating Expenses history runs 11 years deep, the most recent figure standing at $20.5 million for Q3 2025.

• In Q3 2025, Operating Expenses rose 49.78% year-over-year to $20.5 million; the TTM figure through Dec 2025 stood at $58.8 million (up 4.47% YoY), while the FY2024 annual figure was $56.3 million, up 29.11% from the prior year.
• Operating Expenses was $20.5 million for Q3 2025 at Pulse Biosciences, up from $20.3 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $20.5 million in Q3 2025 to a low of $8.7 million in Q4 2022.
• Historically, Operating Expenses has averaged $14.8 million across 5 years, with a median of $14.8 million in 2021.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses sank 46.25% in 2022, then soared 72.91% in 2025.
• A 5-year view of Operating Expenses shows it stood at $16.3 million in 2021, then tumbled by 46.25% to $8.7 million in 2022, then jumped by 43.46% to $12.5 million in 2023, then surged by 61.66% to $20.3 million in 2024, then climbed by 0.95% to $20.5 million in 2025.
• The last three Operating Expenses figures came in at $20.5 million (Q3 2025), $20.3 million (Q2 2025), and $18.0 million (Q1 2025), per Business Quant data.